MD Anderson and Rice launch Cancer Bioengineering Collaborative
The University of Texas MD Anderson Cancer Center and Rice University today announced the creation of the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment.
Led by Rice’s Gang Bao, Ph.D., and MD Anderson’s Jeffrey Molldrem, M.D., the initiative aims to foster collaboration between the two institutions on fundamental and translational...
MD Anderson Research Highlights: EHA 2024 Special Edition
ABSTRACTS: LB3439, LB3442, S131, S132, S136, S164, S222
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases...
MD Anderson and Sibylla Biotech announce strategic collaboration to discover and develop small-molecule protein degraders
The University of Texas MD Anderson Cancer Center and Sibylla Biotech today announced a strategic collaboration agreement to discover and...
Allison Institute announces appointment of two immunobiology experts as associate members
The James P. Allison Institute at The University of Texas MD Anderson Cancer Center today announced the appointment of its newest members, Susan Bullman, Ph.D., and Xi Chen, Ph.D., to further the institute’s ongoing work of impactful immunobiology research. These accomplished researchers, joining as associate members, bring valuable expertise in studying how the intratumoral microbiome and the immune microenvironment influence patient...
